NFKB1 and renal fibrosis: Collectively, these findings indicate that DNMT inhibition by zebularine treatment alleviated the activation of NF-κB and the subsequent inflammatory pathway in obstructed kidneys, which supports the mechanism for the anti-inflammatory effect of zebularine on renal fibrosis.